Invention Publication
- Patent Title: ANTIBODY AND TAXANE COMBINATION THERAPY
-
Application No.: US18038818Application Date: 2021-12-07
-
Publication No.: US20240109972A1Publication Date: 2024-04-04
- Inventor: Ugur SAHIN , Alexander MUIK , Ulf FORSSMANN , Maria JURE-KUNKEL , Manish GUPTA , Tahamtan AHMADI , Kathy AMIRI , Gaurav BAJAJ
- Applicant: Genmab A/S , BioNTech SE
- Applicant Address: DK Copenhagen V
- Assignee: Genmab A/S,BioNTech SE
- Current Assignee: Genmab A/S,BioNTech SE
- Current Assignee Address: DK Copenhagen V
- International Application: PCT/EP2021/084659 2021.12.07
- Date entered country: 2023-05-25
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K31/337 ; A61K45/06 ; A61P35/00
Abstract:
The present invention provides combination therapy to reduce or prevent progression of a tumor or treating cancer in a subject. The combination therapy comprises administration of a binding agent that binds to human CD137 and to human PD-L1; and a taxane chemotherapeutic agent.
Information query
